Optimal management of neutropenic fever in patients with cancer

Andrea J. Zimmer, Alison Gail Freifeld

Research output: Contribution to journalReview article

6 Scopus citations


Febrile neutropenia remains an important complication of treatment with cytotoxic chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this vulnerable patient population. Urgent and appropriate evaluation and treatment are imperative because delay in initiating appropriate antibiotic therapy may be life threatening. Selection of antibiotics should be based on the patient’s symptoms, previous culture data, and institutional antibiograms. Ongoing therapy should be guided by culture and clinical data. Antimicrobial resistance is of great concern, particularly in this population, so careful attention to antibiotic selection and duration is needed.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalJournal of oncology practice
Issue number1
Publication statusPublished - Jan 1 2019


ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this